- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 311
Qiming collects Princeton for $1.1bn fund
Princeton University is a long-standing partner of Qiming Venture Partners, having invested in the latter's inaugural fund back in 2006.
Apr 14, 2020Corporate venturing deal net: 6-9 April 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Apr 9, 2020Daily deal net: April 9, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Apr 9, 2020Deerfield closes $840m fund
Deerfield's second Healthcare Innovations Fund is one and a half times larger than its predecessor and will align with more than 15 university ecosystems.
Apr 9, 2020Keros bosses IPO to raise $96m
Partners Healthcare and Medison Pharma-backed Keros Therapeutics floated at the top of its range and will look to advance its musculoskeletal disorder drug candidates.
Apr 9, 2020Tyto Care takes $50m
The remote diagnostics technology developer increased its total funding to $105m in a round co-led by new investor Qualcomm Ventures.
Apr 9, 2020CyberMDX secures $20m
Mutual insurer Sham has led a $20m round for healthcare cybersecurity software provider CyberMDX that expanded its total funding to $30m.
Apr 8, 2020Daily deal net: April 8, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Apr 8, 2020Genechem generates series C funding
The translational medicine-focused research services provider, which counts Renfu Pharmaceutical as an investor, has completed a Humanwell-backed round sized at about $56m.
Apr 8, 2020Kringle Pharma rings up new funding
Chishima Real Estate and Miraca helped add $6.8m to extend Kringle‘s latest round to $15.5m which will fund development of its rare disease treatments.
Apr 8, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


